Profil
Isabelle Dussault worked as the Global Head-Clinical Biomarker Strategy at EMD Serono, Inc. She then worked as the Senior Vice President-Research at Fusion Pharmaceuticals, Inc. for a year.
Dr. Dussault received her undergraduate and doctorate degrees from McGill University.
Ehemalige bekannte Positionen von Isabelle Dussault
| Unternehmen | Position | Ende |
|---|---|---|
| FUSN PHAR | Corporate Officer/Principal | 01.04.2022 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Ausbildung von Isabelle Dussault
| McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FUSN PHAR | Health Technology |
| Private Unternehmen | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
